Correlation Between Scorpius Holdings and Sonnet Biotherapeutics

Can any of the company-specific risk be diversified away by investing in both Scorpius Holdings and Sonnet Biotherapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Scorpius Holdings and Sonnet Biotherapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Scorpius Holdings and Sonnet Biotherapeutics Holdings, you can compare the effects of market volatilities on Scorpius Holdings and Sonnet Biotherapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Scorpius Holdings with a short position of Sonnet Biotherapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Scorpius Holdings and Sonnet Biotherapeutics.

Diversification Opportunities for Scorpius Holdings and Sonnet Biotherapeutics

0.81

Correlation Coefficient

Scorpius Holdings  Sonnet Biotherapeutics

Very poor diversification

The 3 months correlation between Scorpius and Sonnet is 0.81. Overlapping area represents the amount of risk that can be diversified away by holding Scorpius Holdings and Sonnet Biotherapeutics Holding in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sonnet Biotherapeutics and Scorpius Holdings is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Scorpius Holdings are associated (or correlated) with Sonnet Biotherapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sonnet Biotherapeutics has no effect on the direction of Scorpius Holdings i.e., Scorpius Holdings and Sonnet Biotherapeutics go up and down completely randomly.

Pair Corralation between Scorpius Holdings and Sonnet Biotherapeutics

Given the investment horizon of 90 days Scorpius Holdings is expected to generate 1.71 times more return on investment than Sonnet Biotherapeutics. However, Scorpius Holdings is 1.71 times more volatile than Sonnet Biotherapeutics Holdings. It trades about -0.04 of its potential returns per unit of risk. Sonnet Biotherapeutics Holdings is currently generating about -0.1 per unit of risk. If you would invest  24,200  in Scorpius Holdings on October 8, 2024 and sell it today you would lose (24,146) from holding Scorpius Holdings or give up 99.78% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Strong
Accuracy	100.0%
Values	Daily Returns

Scorpius Holdings  vs.  Sonnet Biotherapeutics Holding

Scorpius Holdings

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Scorpius Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong basic indicators, Scorpius Holdings is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors.

Sonnet Biotherapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Sonnet Biotherapeutics Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in February 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Pair Trading with Scorpius Holdings and Sonnet Biotherapeutics

The main advantage of trading using opposite Scorpius Holdings and Sonnet Biotherapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Scorpius Holdings position performs unexpectedly, Sonnet Biotherapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sonnet Biotherapeutics will offset losses from the drop in Sonnet Biotherapeutics' long position.

The idea behind Scorpius Holdings and Sonnet Biotherapeutics Holdings pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.